119 related articles for article (PubMed ID: 16029038)
1. Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents.
Yan GP; Liu ML; Li LY
Bioconjug Chem; 2005; 16(4):967-71. PubMed ID: 16029038
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents.
Yan GP; Li Z; Xu W; Zhou CK; Yang L; Zhang Q; Li L; Liu F; Han L; Ge YX; Guo JF
Int J Pharm; 2011 Apr; 407(1-2):119-25. PubMed ID: 21272626
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
Yan GP; Hu B; Liu ML; Li LY
J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
5. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
6. Diethylenetriaminepentaacetic acid-gadolinium (DTPA-Gd)-conjugated polysuccinimide derivatives as magnetic resonance imaging contrast agents.
Lee HY; Jee HW; Seo SM; Kwak BK; Khang G; Cho SH
Bioconjug Chem; 2006; 17(3):700-6. PubMed ID: 16704207
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
8. Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI.
Vaccaro M; Mangiapia G; Paduano L; Gianolio E; Accardo A; Tesauro D; Morelli G
Chemphyschem; 2007 Dec; 8(17):2526-38. PubMed ID: 17960748
[TBL] [Abstract][Full Text] [Related]
9. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
10. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
Cheng HL; Wallis C; Shou Z; Farhat WA
J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
[TBL] [Abstract][Full Text] [Related]
12. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
13. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
14. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.
Kiessling F; Heilmann M; Lammers T; Ulbrich K; Subr V; Peschke P; Waengler B; Mier W; Schrenk HH; Bock M; Schad L; Semmler W
Bioconjug Chem; 2006; 17(1):42-51. PubMed ID: 16417250
[TBL] [Abstract][Full Text] [Related]
16. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
Mishra A; Fousková P; Angelovski G; Balogh E; Mishra AK; Logothetis NK; Tóth E
Inorg Chem; 2008 Feb; 47(4):1370-81. PubMed ID: 18166011
[TBL] [Abstract][Full Text] [Related]
17. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
Mohs AM; Lu ZR
Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
[TBL] [Abstract][Full Text] [Related]
19. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
20. PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.
Mohs AM; Zong Y; Guo J; Parker DL; Lu ZR
Biomacromolecules; 2005; 6(4):2305-11. PubMed ID: 16004476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
